Apolipoprotein C2 DeficiencySymptoms, Doctors, Treatments, Advances & More
Apolipoprotein C2 Deficiency Overview
Learn About Apolipoprotein C2 Deficiency
Condition 101 content is not available at this time, but we are continually updating the site. Please check back.
However, there may be experts who have treated this or similar conditions in our Find a Doctor section and research may be available in our Latest Advances section.
Daniel Gaudet practices practicing medicine in Montreal, Canada. Mr. Gaudet is rated as an Elite expert by MediFind in the treatment of Apolipoprotein C2 Deficiency. He is also highly rated in 19 other conditions, according to our data. His clinical expertise encompasses High Cholesterol, Familial Hypertriglyceridemia, Familial Lipoprotein Lipase Deficiency, and Apolipoprotein C2 Deficiency.
Diane Brisson practices practicing medicine in Chicoutimi, Canada. Ms. Brisson is rated as an Elite expert by MediFind in the treatment of Apolipoprotein C2 Deficiency. She is also highly rated in 16 other conditions, according to our data. Her clinical expertise encompasses Apolipoprotein C2 Deficiency, Familial Lipoprotein Lipase Deficiency, High Cholesterol, and Familial Hypertriglyceridemia.
Office
Joseph Witztum is an Endocrinologist practicing medicine in La Jolla, California. Dr. Witztum is rated as an Elite provider by MediFind in the treatment of Apolipoprotein C2 Deficiency. He is also highly rated in 4 other conditions, according to our data. His clinical expertise encompasses Apolipoprotein C2 Deficiency, Familial Lipoprotein Lipase Deficiency, Familial Hypertriglyceridemia, and Antigen-Peptide-Transporter 2 Deficiency. Dr. Witztum is currently accepting new patients.
Summary: The primary purpose of the study is to evaluate the efficacy of olezarsen administered by subcutaneous injection to pediatric participants with FCS.
Summary: Type I hyperlipoproteinemia (T1HLP, also known as familial chylomicronemia syndrome or FCS) is a rare diseasewhere the blood triglycerides (fats) are very high. It is caused by lack of certain enzymes and proteins in the bodythat are important in disposing circulating fats from blood. Treatment of T1HLP patients who have very high levels of blood fats (≥ 1,000 mg/dL) is challenging as conventional...